These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38626061)

  • 1. Association between dyslipidemia and the risk of incident chronic kidney disease affected by genetic susceptibility: Polygenic risk score analysis.
    Weon B; Jang Y; Jo J; Jin W; Ha S; Ko A; Oh YK; Lim CS; Lee JP; Won S; Lee J
    PLoS One; 2024; 19(4):e0299605. PubMed ID: 38626061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of blood lipid profile with incident chronic kidney disease: A Mendelian randomization study.
    Zhang YB; Sheng LT; Wei W; Guo H; Yang H; Min X; Guo K; Yang K; Zhang X; He M; Wu T; Pan A
    Atherosclerosis; 2020 May; 300():19-25. PubMed ID: 32276134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDL Cholesterol, LDL Cholesterol, and Triglycerides as Risk Factors for CKD: A Mendelian Randomization Study.
    Lanktree MB; Thériault S; Walsh M; Paré G
    Am J Kidney Dis; 2018 Feb; 71(2):166-172. PubMed ID: 28754456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD.
    Lamprea-Montealegre JA; Staplin N; Herrington WG; Haynes R; Emberson J; Baigent C; de Boer IH;
    Clin J Am Soc Nephrol; 2020 Jan; 15(1):47-60. PubMed ID: 31831577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating linear and nonlinear associations of LDL cholesterol with incident chronic kidney disease, atherosclerotic cardiovascular disease and all-cause mortality: A prospective and Mendelian randomization study.
    Wang Z; Xiao Y; Lu J; Zou C; Huang W; Zhang J; Liu S; Han L; Jiao F; Tian D; Jiang Y; Du X; Ma RCW; Jiang G
    Atherosclerosis; 2023 Dec; 387():117394. PubMed ID: 38029611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LDL-C/apoB and HDL-C/apoA-1 ratios predict incident chronic kidney disease in a large apparently healthy cohort.
    Bae JC; Han JM; Kwon S; Jee JH; Yu TY; Lee MK; Kim JH
    Atherosclerosis; 2016 Aug; 251():170-176. PubMed ID: 27341533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive assessment of the combined impact of dyslipidemia and inflammation on chronic kidney disease development: A prospective cohort study.
    Yoon J; Han T; Heo SJ; Kwon YJ
    J Clin Lipidol; 2024; 18(2):e251-e260. PubMed ID: 38233308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of genetic variants with dyslipidemia and chronic kidney disease in a longitudinal population-based genetic epidemiological study.
    Yamada Y; Matsui K; Takeuchi I; Fujimaki T
    Int J Mol Med; 2015 May; 35(5):1290-300. PubMed ID: 25813695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease.
    Pennell P; Leclercq B; Delahunty MI; Walters BA
    Clin Nephrol; 2006 Nov; 66(5):336-47. PubMed ID: 17140163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the TG/HDL-C and Non-HDL-C/HDL-C Ratios with Chronic Kidney Disease in an Adult Chinese Population.
    Wen J; Chen Y; Huang Y; Lu Y; Liu X; Zhou H; Yuan H
    Kidney Blood Press Res; 2017; 42(6):1141-1154. PubMed ID: 29224024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between chronic kidney disease and new-onset dyslipidemia: The Japan Specific Health Checkups (J-SHC) study.
    Kosugi T; Eriguchi M; Yoshida H; Tasaki H; Fukata F; Nishimoto M; Matsui M; Samejima KI; Iseki K; Fujimoto S; Konta T; Moriyama T; Yamagata K; Narita I; Kasahara M; Shibagaki Y; Kondo M; Asahi K; Watanabe T; Tsuruya K;
    Atherosclerosis; 2021 Sep; 332():24-32. PubMed ID: 34375910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes.
    Zoppini G; Targher G; Chonchol M; Perrone F; Lippi G; Muggeo M
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):580-6. PubMed ID: 19196499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low HDL cholesterol as a predictor of chronic kidney disease progression: a cross-classification approach and matched cohort analysis.
    Kawachi K; Kataoka H; Manabe S; Mochizuki T; Nitta K
    Heart Vessels; 2019 Sep; 34(9):1440-1455. PubMed ID: 30874893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the Triglycerides to High-Density Lipoprotein Cholesterol Ratio on the Incidence and Progression of CKD: A Longitudinal Study in a Large Japanese Population.
    Tsuruya K; Yoshida H; Nagata M; Kitazono T; Iseki K; Iseki C; Fujimoto S; Konta T; Moriyama T; Yamagata K; Narita I; Kimura K; Kondo M; Asahi K; Kurahashi I; Ohashi Y; Watanabe T
    Am J Kidney Dis; 2015 Dec; 66(6):972-83. PubMed ID: 26145254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear Magnetic Resonance-Based Metabolomics and Risk of CKD.
    Geng TT; Chen JX; Lu Q; Wang PL; Xia PF; Zhu K; Li Y; Guo KQ; Yang K; Liao YF; Zhou YF; Liu G; Pan A
    Am J Kidney Dis; 2024 Jan; 83(1):9-17. PubMed ID: 37678743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of lipid-related ratios for prediction of chronic kidney disease stage 3 or more in Korean adults.
    Kim JY; Kang HT; Lee HR; Lee YJ; Shim JY
    J Korean Med Sci; 2012 Dec; 27(12):1524-9. PubMed ID: 23255852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the triglycerides to high-density lipoprotein cholesterol ratio with the risk of chronic kidney disease: analysis in a large Japanese population.
    Tsuruya K; Yoshida H; Nagata M; Kitazono T; Hirakata H; Iseki K; Moriyama T; Yamagata K; Yoshida H; Fujimoto S; Asahi K; Kurahashi I; Ohashi Y; Watanabe T
    Atherosclerosis; 2014 Mar; 233(1):260-7. PubMed ID: 24529154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ratio of triglycerides to high-density lipoprotein cholesterol is associated with the risk of chronic kidney disease in Korean men.
    Kim J; Bae YJ; Shin SJ; You HS; Lee JW; Kang HT
    Lipids; 2021 Sep; 56(5):475-483. PubMed ID: 34089267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between different levels and patterns of dyslipidemia and glomerular filtration rate in patients with type 2 diabetes: A cross-sectional survey of a regional cohort.
    Yadegar A; Mohammadi F; Rabizadeh S; Ayati A; Seyedi SA; Nabipoorashrafi SA; Esteghamati A; Nakhjavani M
    J Clin Lab Anal; 2023 Jul; 37(13-14):e24954. PubMed ID: 37537785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low levels of high-density lipoprotein cholesterol increase the risk of incident kidney disease and its progression.
    Bowe B; Xie Y; Xian H; Balasubramanian S; Al-Aly Z
    Kidney Int; 2016 Apr; 89(4):886-96. PubMed ID: 26924057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.